Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC
and STRCW, a leader in advanced robotic technology designed to
increase the intelligence, efficiency, capability and productivity
of advanced robotic systems through applied autonomy, today
announced financial results for the quarter ended September 30,
2023.
Highlights
- Laura Peterson appointed as
President and CEO; Ben Wolff, co-founder and Board member named
Executive Vice Chairman
- Sarcos artificial intelligence (AI)
and machine learning (ML) software business bolstered by $13.8
million contract from the U.S. Air Force to advance its AI/ML
software
- Pivoting business to focus on
robotic AI/ML software platform; aligning cost structure with
business priorities
CEO Commentary
“Since I assumed the role of CEO in May, our
leadership team has conducted an ongoing rigorous, data-driven
analysis and review of our business, market opportunities, products
and development programs,” said Laura Peterson, President and Chief
Executive Officer of Sarcos.
“With the consideration of our cash position, as well as third
party dependencies, customer decision timing, and the cost and time
to achieve a significant and steady revenue stream from our
hardware products, it was clear that we should adjust course
rapidly to right size the company and get our cash usage down to a
level that we believe will provide the best opportunity for success
with our available resources. We made the decisions to suspend our
hardware commercialization efforts, implement a significant
reduction in force and focus our resources on our AI/ML
platform.
“By de-coupling our advanced AI/ML software from our own robotic
systems, we believe we have the opportunity to reach a much broader
market more quickly by targeting existing deployed robotic systems
and new sales of third-party systems. We can provide customers with
the solutions they need through the intellectual capital that
Sarcos brings to the table, but without requiring significant
investment in hardware development and production.
“In addition, as previously announced, we already have AI
software-related contracts with various U.S. government agencies,
including a $13.8 million, four-year development contract with the
U.S. Airforce to advance artificial intelligence and machine
learning software. The contract supports the development,
integration and validation of our AI and ML software framework for
success-based learning, which will allow robots to perceive their
environment, determine reasonable behavior in unforeseen
situations, and quickly change their actions.
“In connection with our plans to focus on
robotic AI/ML software, we are realigning our resources, including
taking steps to reduce our headcount and operating expenses, which
we expect to result in a significant reduction in our monthly cash
usage after the restructuring is completed.”
Q3 Financial Results
Third quarter 2023 total revenue was $1.8
million, compared to $4.7 million during the third quarter of 2022.
Revenues decreased on a year-over-year basis as a result of fewer
product development contracts being worked during the current year,
offset slightly by an increase in product revenue.
Total operating expenses for the third quarter
of 2023 were $32.6 million, compared to operating expenses of $31.9
million during the third quarter of 2022. In connection with the
July 12, 2023, announced restructuring, the Company incurred
charges of $5.5 million in the third quarter of 2023, including
$1.1 million in severance and benefit payments and $4.4 million due
to the acceleration of stock-based compensation expense resulting
from the early termination of the Company's redemption right over
certain shares held by the Company's former Chief Operating Officer
in connection with the termination of his employment. Further,
reflecting the restructuring actions announced today, the Company
incurred $5.7 million of restructuring costs in the third quarter
2023, including a write-down of inventory of $5.2 million and $0.5
million related to the write-down of certain assets. Cost of
revenue decreased to $1.2 million in the third quarter 2023 as
compared to $3.6 million in the third quarter 2022, mainly due to
decreased labor and material expenses charged to product
development contracts. Third quarter 2023 gross margin was 33%,
compared to 23% in the third quarter of 2022.
Research and development expenses decreased to
$10.0 million in the third quarter 2023 as compared to $10.5
million in the third quarter of 2022, due mainly to reduced third
party professional service expenses connected with our
prioritization of efforts. General and administrative expenses
decreased to $7.6 million in Q3 2023 as compared to $14.6 million
in the third quarter 2022, primarily due to decreased stock-based
compensation expenses.
Third quarter 2023 net loss was $29.0 million or
$1.13 per share, compared to a net loss of $22.5 million or $0.89
per share in the third quarter of the prior year.
Third quarter 2023 non-GAAP net loss was $17.0
million or $0.66 per diluted share. Reconciliation of net loss to
non-GAAP net loss is included at the end of this release.
Sarcos ended the quarter with $55.1 million in
unrestricted cash, cash equivalents, and marketable securities.
Financial GuidanceDue to the
many variables associated with the organizational and business
changes announced today, we will not provide revenue guidance for
the fourth quarter. We expect to end the year with approximately
$39 million of cash, cash equivalents and marketable securities.
Further, we expect net cash usage should average approximately $1.6
million per month in 2024, which could be reduced further by
revenue realized from customer purchases of the service.
We anticipate incurring additional restructuring
expenses, related to the restructuring actions taken during 2023,
in the range of $22 million to $24 million during the fourth
quarter of 2023 and the first quarter of 2024. These expenses
include approximately $4 million dollars in personnel expenses such
as salaries, wages, benefits and severance related to the
eliminated headcount. The remainder will be non-cash expenses
related to expected accelerated amortization of intangible and
other assets due to the strategic shift initiated during the fourth
quarter.
Conference Call and Webcast
A conference call and audio webcast with
analysts and investors will be held today at 4:30 p.m. Eastern
Time/1:30 p.m. Pacific Time to discuss the results and answer
questions.
- To access the conference call,
please pre-register using this link. Registrants will receive
confirmation with dial-in details.
- Live and archived webcast will be
available on Sarcos investor relations website at
investor.sarcos.com.
About Sarcos Technology and Robotics
Corporation
Sarcos Technology and Robotics Corporation
(NASDAQ: STRC and STRCW) is a leader in advanced robotic technology
designed to increase the intelligence, efficiency, capability and
productivity of advanced robotic systems. Sarcos robotic artificial
intelligence and machine learning software enables generalizable
autonomy to address challenging, dynamic, environments for
industries that require a high degree of adaptability and
efficiency. For more information, please visit www.sarcos.com and
connect with us on LinkedIn at www.linkedin.com/company/sarcos.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements regarding the timing and
amount of revenues and revenue growth, products to be
commercialized, the creation of long-term value, product
capabilities and functionality including reductions in robotic
training times achieved by Sarcos’ software platform, future cash
usage and balances and future restructuring costs. Forward-looking
statements are inherently subject to risks, uncertainties, and
assumptions. Generally, statements that are not historical facts,
including statements concerning possible, intended, or assumed
future actions, business strategies, events, business conditions or
results of operations, are forward-looking statements. These
statements may be preceded by, followed by, or include the words
“believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,”
“will,” “aim,” “should,” “seeks,” “plans,” “scheduled,”
“anticipates,” “intends” or “continue” or similar expressions. Such
forward-looking statements involve risks and uncertainties that may
cause actual events, results, or performance to differ materially
from those indicated by such statements. These forward-looking
statements are based on Sarcos’ management’s current expectations
and beliefs, as well as a number of assumptions concerning future
events. However, there can be no assurance that the events,
results, or trends identified in these forward-looking statements
will occur or be achieved. Forward-looking statements speak only as
of the date they are made, and Sarcos is not under any obligation
and expressly disclaims any obligation, to update, alter or
otherwise revise any forward-looking statement, whether as a result
of new information, future events, or otherwise, except as required
by law.
Readers should carefully review the statements
set forth in the reports which Sarcos has filed or will file from
time to time with the Securities and Exchange
Commission (the “SEC”), in particular the risks and
uncertainties set forth in the sections of those reports entitled
“Risk Factors” and “Cautionary Note Regarding Forward-Looking
Statements,” for a description of risks facing Sarcos and that
could cause actual events, results or performance to differ from
those indicated in the forward-looking statements contained herein.
The documents filed by Sarcos with the SEC may be
obtained free of charge at the SEC’s website
at www.sec.gov.
SARCOS TECHNOLOGY AND ROBOTICS
CORPORATIONCONDENSED CONSOLIDATED BALANCE
SHEETS(Unaudited)(in thousands, except
share data) |
|
|
|
|
|
As of |
|
|
|
September 30, 2023 |
|
|
December 31, 2022 |
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
35,310 |
|
|
$ |
35,159 |
|
Marketable securities |
|
|
19,811 |
|
|
|
79,337 |
|
Accounts receivable |
|
|
1,402 |
|
|
|
1,866 |
|
Unbilled receivables |
|
|
1,613 |
|
|
|
4,160 |
|
Inventories, net |
|
|
1,108 |
|
|
|
3,562 |
|
Prepaid expenses and other current assets |
|
|
2,146 |
|
|
|
5,015 |
|
Total current assets |
|
|
61,390 |
|
|
|
129,099 |
|
Property and equipment, net |
|
|
6,693 |
|
|
|
7,640 |
|
Intangible assets, net |
|
|
16,660 |
|
|
|
19,116 |
|
Operating lease assets |
|
|
10,394 |
|
|
|
11,283 |
|
Other non-current assets |
|
|
446 |
|
|
|
487 |
|
Total assets |
|
$ |
95,583 |
|
|
$ |
167,625 |
|
Liabilities and
stockholders’ equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable |
|
$ |
2,056 |
|
|
$ |
3,620 |
|
Accrued liabilities |
|
|
4,580 |
|
|
|
6,025 |
|
Current operating lease liabilities |
|
|
1,311 |
|
|
|
887 |
|
Total current liabilities |
|
|
7,947 |
|
|
|
10,532 |
|
Operating lease liabilities |
|
|
11,389 |
|
|
|
12,387 |
|
Other non-current liabilities |
|
|
92 |
|
|
|
256 |
|
Total liabilities |
|
|
19,428 |
|
|
|
23,175 |
|
Commitments and
contingencies |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
Common stock, $0.0001 par value,
165,000,000 shares authorized as of September 30, 2023, and
December 31, 2022; 25,850,832 and 25,708,519 shares issued and
outstanding as of September 30, 2023, and December 31, 2022,
respectively |
|
|
3 |
|
|
|
3 |
|
Additional paid-in capital |
|
|
457,888 |
|
|
|
447,085 |
|
Accumulated other comprehensive
income (loss) |
|
|
2 |
|
|
|
(17 |
) |
Accumulated deficit |
|
|
(381,738 |
) |
|
|
(302,621 |
) |
Total stockholders’ equity |
|
|
76,155 |
|
|
|
144,450 |
|
Total liabilities and
stockholders’ equity |
|
$ |
95,583 |
|
|
$ |
167,625 |
|
See Sarcos 10-Q filing dated November 14, 2023,
for accompanying notes to the consolidated financial
statements.
SARCOS TECHNOLOGY AND ROBOTICS
CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS(Unaudited)(in thousands,
except share and per share data) |
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Revenue, net |
|
$ |
1,827 |
|
|
$ |
4,667 |
|
|
$ |
5,400 |
|
|
$ |
8,448 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue (exclusive of items shown separately below) |
|
|
1,222 |
|
|
|
3,578 |
|
|
|
3,951 |
|
|
|
7,212 |
|
Research and development |
|
|
10,011 |
|
|
|
10,497 |
|
|
|
31,120 |
|
|
|
23,947 |
|
General and administrative |
|
|
7,557 |
|
|
|
14,646 |
|
|
|
25,544 |
|
|
|
50,584 |
|
Sales and marketing |
|
|
1,750 |
|
|
|
2,405 |
|
|
|
9,901 |
|
|
|
7,202 |
|
Intangible amortization expense |
|
|
819 |
|
|
|
791 |
|
|
|
2,457 |
|
|
|
1,365 |
|
Asset write-down and restructuring |
|
|
11,222 |
|
|
|
— |
|
|
|
16,328 |
|
|
|
— |
|
Total operating expenses |
|
|
32,581 |
|
|
|
31,917 |
|
|
|
89,301 |
|
|
|
90,310 |
|
Loss from operations |
|
|
(30,754 |
) |
|
|
(27,250 |
) |
|
|
(83,901 |
) |
|
|
(81,862 |
) |
Interest income, net |
|
|
806 |
|
|
|
806 |
|
|
|
2,779 |
|
|
|
965 |
|
Gain on warrant liability |
|
|
96 |
|
|
|
1,484 |
|
|
|
99 |
|
|
|
12,011 |
|
Other income (loss), net |
|
|
871 |
|
|
|
(4 |
) |
|
|
1,909 |
|
|
|
(4 |
) |
Loss before income tax benefit
(expense) |
|
|
(28,981 |
) |
|
|
(24,964 |
) |
|
|
(79,114 |
) |
|
|
(68,890 |
) |
Income tax benefit (expense) |
|
|
— |
|
|
|
2,465 |
|
|
|
(3 |
) |
|
|
4,071 |
|
Net loss |
|
$ |
(28,981 |
) |
|
$ |
(22,499 |
) |
|
$ |
(79,117 |
) |
|
$ |
(64,819 |
) |
Net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(1.13 |
) |
|
$ |
(0.89 |
) |
|
$ |
(3.09 |
) |
|
$ |
(2.68 |
) |
Weighted-average shares used in
computing net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
25,706,023 |
|
|
|
25,156,756 |
|
|
|
25,563,895 |
|
|
|
24,180,445 |
|
See Sarcos 10-Q filing dated November 14, 2023,
for accompanying notes to the consolidated financial
statements.
SARCOS TECHNOLOGY AND ROBOTICS
CORPORATIONCONDENSED CONSOLIDATED STATEMENT OF CASH
FLOWS(Unaudited)(in thousands) |
|
|
|
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
Cash flows from operating
activities: |
|
|
|
|
|
|
Net loss |
|
$ |
(79,117 |
) |
|
$ |
(64,819 |
) |
Adjustments to reconcile net loss
to net cash used in operating activities: |
|
|
|
|
|
|
Stock-based compensation |
|
|
10,808 |
|
|
|
29,586 |
|
Depreciation of property and equipment |
|
|
1,261 |
|
|
|
954 |
|
Amortization of intangible assets |
|
|
2,457 |
|
|
|
1,365 |
|
Change in fair value of warrant liability |
|
|
(99 |
) |
|
|
(12,011 |
) |
Amortization of investment discount |
|
|
(1,833 |
) |
|
|
(690 |
) |
Asset write-down |
|
|
10,827 |
|
|
|
— |
|
Changes in operating assets and
liabilities |
|
|
|
|
|
|
Accounts receivable |
|
|
465 |
|
|
|
(991 |
) |
Unbilled receivable |
|
|
2,547 |
|
|
|
367 |
|
Inventories |
|
|
(7,169 |
) |
|
|
(1,747 |
) |
Prepaid expenses and other current assets |
|
|
2,343 |
|
|
|
6,407 |
|
Other non-current assets |
|
|
930 |
|
|
|
634 |
|
Accounts payable |
|
|
(1,525 |
) |
|
|
549 |
|
Accrued liabilities |
|
|
(1,021 |
) |
|
|
363 |
|
Other non-current liabilities |
|
|
(997 |
) |
|
|
(4,415 |
) |
Net cash used in operating
activities |
|
|
(60,123 |
) |
|
|
(44,448 |
) |
Cash flows from investing
activities: |
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(1,033 |
) |
|
|
(1,046 |
) |
Acquisition of a business, net of cash acquired |
|
— |
|
|
|
(29,687 |
) |
Purchases of marketable securities |
|
|
(58,622 |
) |
|
|
(138,696 |
) |
Maturities of marketable securities |
|
|
120,000 |
|
|
|
20,000 |
|
Net cash provided by (used in)
investing activities |
|
|
60,345 |
|
|
|
(149,429 |
) |
Cash flows from financing
activities: |
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
|
— |
|
|
|
663 |
|
Shares repurchased for payment of tax withholdings |
|
|
(68 |
) |
|
|
(7,677 |
) |
Payment of obligations under capital leases |
|
|
(3 |
) |
|
|
(94 |
) |
Net cash used in financing
activities |
|
|
(71 |
) |
|
|
(7,108 |
) |
Net increase (decrease) in cash,
cash equivalents |
|
|
151 |
|
|
|
(200,985 |
) |
Cash and cash equivalents at
beginning of period |
|
|
35,159 |
|
|
|
217,114 |
|
Cash and cash equivalents at end
of period |
|
$ |
35,310 |
|
|
$ |
16,129 |
|
Supplemental disclosure
of cash flow information: |
|
|
|
|
|
|
Cash paid for income taxes |
|
$ |
3 |
|
|
$ |
— |
|
Supplemental disclosure
of non-cash activities: |
|
|
|
|
|
|
Common stock and assumed equity
awards in connection with a business acquisition |
|
$ |
— |
|
|
$ |
59,410 |
|
Purchases of property and
equipment included in accounts payable at period-end |
|
$ |
— |
|
|
$ |
13 |
|
See Sarcos 10-Q filing dated November 14, 2023,
for accompanying notes to the consolidated financial
statements.
SARCOS TECHNOLOGY AND ROBOTICS CORPORATIONREVENUE
BY TYPE(Unaudited)(in thousands) |
|
|
|
|
|
Three Months EndedSeptember 30, |
|
|
Nine Months
EndedSeptember 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Product Development Contract Revenue |
|
$ |
1,044 |
|
|
$ |
4,488 |
|
|
$ |
4,614 |
|
|
$ |
8,203 |
|
Product Revenue |
|
|
783 |
|
|
|
179 |
|
|
|
786 |
|
|
|
245 |
|
Revenue, net |
|
$ |
1,827 |
|
|
$ |
4,667 |
|
|
$ |
5,400 |
|
|
$ |
8,448 |
|
SARCOS TECHNOLOGY AND ROBOTICS
CORPORATIONNON-GAAP FINANCIAL
MEASURES(Unaudited)
To supplement our financial statements presented
in accordance with GAAP and to provide investors with additional
information regarding our financial results, we have presented in
this release non-GAAP net loss and non-GAAP net loss per share,
each of which are non-GAAP financial measures. Non-GAAP net loss
and non-GAAP net loss per share are not based on any standardized
methodology prescribed by GAAP and are not necessarily comparable
to similarly titled measures presented by other companies.
We define non-GAAP net loss as our GAAP measured
net loss excluding the impacts of stock-based compensation expense,
gain on forgiveness of notes payable, gain or loss on change in
fair value of derivative instruments and warrant liabilities,
expenses related to a business combination, asset write-down and
restructuring expenses, goodwill impairment and other non-recurring
non-operating expenses. We define non-GAAP net loss per share as
non-GAAP net loss divided by weighted average outstanding
shares.
The most directly comparable GAAP measure to
non-GAAP net loss is net loss. The most directly comparable GAAP
measure to non-GAAP net loss per share is net loss per share. We
believe excluding the impact of the previously listed items in
calculating non-GAAP net loss and non-GAAP net loss per share can
provide a useful measure for period-to-period comparisons of our
core operating performance. We monitor, and have presented in this
release, non-GAAP net loss and non-GAAP net loss per share because
they are each a key measure used by our management and board of
directors to understand and evaluate our operating performance and
to establish budgets. We believe non-GAAP net loss and non-GAAP net
loss per share help identify underlying trends in our business that
could otherwise be masked by the effect of the expenses that we
include in net loss but not in non-GAAP net loss. Accordingly, we
believe non-GAAP net loss and non-GAAP net loss per share provide
useful information to investors, analysts and others in
understanding and evaluating our operating results, enhancing the
overall understanding of our past performance.
Non-GAAP net loss and non-GAAP net loss per
share are not prepared in accordance with GAAP and should not be
considered in isolation of, or as an alternative to, measures
prepared in accordance with GAAP. There are a number of limitations
related to the use of non-GAAP net loss and non-GAAP net loss per
share rather than net loss and net loss per share, which is for
each the most directly comparable financial measure calculated and
presented in accordance with GAAP. In addition, the expenses and
other items that we exclude in our calculations of non-GAAP net
loss and non-GAAP net loss per share may differ from the expenses
and other items, if any, that other companies may exclude from
non-GAAP net loss and non-GAAP net loss per share when they report
their operating results, limiting the usefulness of non-GAAP net
loss and non-GAAP net loss per share for comparative purposes.
In addition, other companies may use other
measures to evaluate their performance, all of which could reduce
the usefulness of non-GAAP net loss and non-GAAP net loss per share
as tools for comparison.
The following table reconciles non-GAAP net loss
to net loss, the most directly comparable financial measure
calculated and presented in accordance with GAAP (in thousands,
except share and per share data):
|
|
Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Net loss |
|
$ |
(28,981 |
) |
|
$ |
(22,499 |
) |
|
$ |
(79,117 |
) |
|
$ |
(64,819 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
1,679 |
|
|
|
8,466 |
|
|
|
6,413 |
|
|
|
29,586 |
|
Gain on warrant liability |
|
|
(96 |
) |
|
|
(1,484 |
) |
|
|
(99 |
) |
|
|
(12,011 |
) |
Asset write-down and restructuring(1) |
|
|
11,222 |
|
|
|
— |
|
|
|
16,328 |
|
|
|
— |
|
Employee Retention Credit |
|
|
(876 |
) |
|
|
— |
|
|
|
(1,895 |
) |
|
|
— |
|
Expenses related to business combinations(2) |
|
|
— |
|
|
|
(591 |
) |
|
|
— |
|
|
|
1,935 |
|
Income tax benefit related to business combinations |
|
|
— |
|
|
|
(2,465 |
) |
|
|
— |
|
|
|
(4,071 |
) |
Non-GAAP net loss |
|
$ |
(17,052 |
) |
|
$ |
(18,573 |
) |
|
$ |
(58,370 |
) |
|
$ |
(49,380 |
) |
Net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(1.13 |
) |
|
$ |
(0.89 |
) |
|
$ |
(3.09 |
) |
|
$ |
(2.68 |
) |
Non-GAAP net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
$ |
(0.66 |
) |
|
$ |
(0.74 |
) |
|
$ |
(2.28 |
) |
|
$ |
(2.04 |
) |
Weighted-average shares used in
computing net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
25,706,023 |
|
|
|
25,156,756 |
|
|
|
25,563,895 |
|
|
|
24,180,445 |
|
1) Expenses related to our asset write-down and
restructuring for the three months ended September 30, 2023,
includes $1.1 million in cash severance and benefit payments, $4.4
million related to the acceleration of stock-based compensation
expense, $5.2 million due to the write-down of inventory, and a
$0.5 million impairment charge for certain assets as a result of
our product development reprioritization. Expenses related to our
asset write-down and restructuring for the nine months ended
September 30, 2023, includes $1.1 million in cash severance
and benefit payments, $4.4 million related to the acceleration of
stock-based compensation expense, $9.6 million due to the
write-down of inventory, and a $1.2 million impairment charge for
certain assets as a result of our product development
reprioritization.
2) Expenses related to our business combination
with RE2, Inc., which are included within general and
administrative expenses within the condensed consolidated
statements of operations.
Investor Contact: Julie KegleyFinancial
Profiles310.622.8246STRC@finprofiles.com
Press Contact:Tricia RossFinancial
Profiles310.622.8226STRC@finprofiles.com
Palladyne AI (NASDAQ:STRC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Palladyne AI (NASDAQ:STRC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024